Hide Board Information

Show Board Information

Psyched Wellness Ltd. PSYCF

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/28/2020 10:45:50 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Psyched Wellness Ltd. (OTCMRKTS: PSYCF) Stock Message Board

1. PSYCF Company Profile

    

2. PSYCF Time & Sales

    

3. PSYCF Recent News

    

4. PSYCF Filings

    

5. PSYCF Financials

    

6. PSYCF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$DCNPF News Article - Psyched Wellness Has	whytestocks	12/28/2020 10:45:50 AM
5	$DCNPF News Article - Psyched Wellness	whytestocks	12/10/2020 10:55:48 AM
4	DCNPF Financials Tuesday, July 15, 2014 06:49:01	Emylers	07/15/2014 6:49:03 AM
3	Latest Duncan Pk Hldgs (DCNPF) Headlines Duncan	Stock_Tracker	03/09/2014 2:07:13 PM
2	DCNPF 0.0021 Stock Charts $DCNPF 1 Month Chart	chartguy89	03/06/2014 7:22:42 PM
1	DCNPF Stock Charts Last: -0.0018 Tuesday,	chartguy89	02/25/2014 7:27:56 AM

Recent Articles

• Discover How Altria, Mastercard, and Ulta Can Build Your Wealth
• Live Oak Bancshares Announces New Depositary Share Offering
• Slide Insurance Holdings Set to Share Q2 Results Soon
• Earnings Anticipation for LendingClub: Key Insights Ahead
• Twin Hospitality Group's Exciting Financial Updates for Investors
• NexPoint Residential: What to Expect from Earnings Ahead
• Expectations for Teladoc Health's Upcoming Earnings Report
• Understanding Tetra Technologies: Prior Earnings and Future Prospects
• Insights on Expro Group Holdings' Quarterly Performance Ahead
• Understanding Okeanis Eco Tankers and Its Earnings Outlook
• Surge Energy Reports Strong Q2 Results: Production Forecast Up
• Grupo Comercial Chedraui Reports Strong Second Quarter Results
• Emerging Opportunities in Alpha-synuclein Inhibitors Market Growth
• FIBRA Prologis Reports Strong Q2 2025 Earnings Insights
• Key Insights for Investors Ahead of Meta Platforms Q2 Earnings
• Abercrombie & Fitch: An In-Depth Look at Its Value Prospects
• Strategic Decisions Following Bankruptcy: Nano Dimension Insights
• Qualigen Therapeutics Updates on Nasdaq Listing Compliance Efforts
• FAT Brands Set to Reveal Second Quarter Financial Insights
• Unlocking Long-Term Growth: The Journey of Texas Instruments
• Grupo Comercial Chedraui Reports Strong Second Quarter Performance
• Empowering Recovery: Join the Opioid Summit for Veterans
• Market Insights: Key Earnings Reports and Trends Ahead
• Understanding the Centene Corporation Class Action Lawsuit
• Understanding the Recent Legal Challenges Facing Reddit, Inc.
• Investors Rally Behind Hims & Hers Amid Class Action Lawsuit
• Brown & Brown, Inc. Reports Significant Growth in Q2 2025
• Investor Alert: Legal Action for Sarepta Therapeutics Losses
• Upcoming Earnings Call for Maravai LifeSciences: Key Insights
• Class Action Notice: Hims & Hers Investors Can Recover Losses
• Investors Alert: Hims & Hers Faces Class Action Lawsuit Risks
• Sarepta Therapeutics Facing Class Action Lawsuit Amid Concerns
• Analyzing CRH Inc's Earnings Performance and Market Trends
• How New Regulations Impact Startups in the Stablecoin Market
• Paramount Global Prepares for Q2 2025 Results Announcement
• SDGE Honored With Two Awards for Excellence in Operations
• Energizer Holdings Announces Exciting Dividend for Investors
• Investors Invited to Lead Class Action Against Rocket Pharmaceuticals
• Chris Hannan Joins Jones Walker's Maritime Practice in New Orleans
• Howard Hughes Holdings Reports Strong Sales in Top Communities
• Enovix Corporation Announces Early Warrant Expiration Details
• Tempus AI Inc Faces Class Action Amid Accusations of Fraud
• Enovix Corp Gears Up for Earnings, Manufacturing Goals Tested
• iRobot Corporation Faces Class Action Risk: What Investors Should Know
• Reckitt Benckiser Group PLC Class Action Overview for Investors
• The Incredible Growth of HubSpot: A $100 Investment Journey
• Cadence Design Systems Reports Strong Earnings and Outlook
• Leadership Transition at MSC Industrial Supply Co. Amid Growth
• Scotch Brand Commemorates a Century of Innovation and Trust
• Capricor Therapeutics Securities Fraud: Join the Class Action